出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2022年12月
ヘルスケア分析市場 : タイプ (記述的、予測的、認知的)、用途 (金融、RCM、詐欺、臨床、運用)、コンポーネント (サービス、ソフトウェア)、展開 (オンプレミス、クラウド)、エンドユーザー (病院、支払者) – 2027年までの世界予測
Healthcare Analytics Market by Type (Descriptive, Predictive, Cognitive), Application (Financial, RCM, Fraud, Clinical, Operational), Component (Services, Software), Deployment (on premise, Cloud), End-user (Hospitals, Payer) – Global Forecast to 2027
| ページ数 | 323 |
| 図表数 | 328 |
| 種別 | 英文調査報告書 |
| 価格 |
The global healthcare analytics market is projected to reach USD 85.9 billion by 2027 from USD 27.4 billion in 2022, at a CAGR of 25.7% during the forecast period. The healthcare analytics market is mainly driven by factors such as increasing amount of venture capital investments and implementation of federal health mandates that encourage the adoption of HCIT solutions. However, poorly connected IT infrastructure, data security issues, and low budget allocations of hospitals for implementing HCIT solutions are likely to restrain growth of this market.
Descriptive analytics type segment holds the largest share of the healthcare analytics market in 2021”
On the basis of type, the market is segmented into cognitive analytics, descriptive analytics, predictive analytics, and prescriptive analytics. In 2021, the descriptive analytics segment hold the largest share of the healthcare analytics market. The large share of this segment is primarily attributed because descriptive analytics help healthcare payers and providers to enhance and manage their business practices.
Clinical analytics segment is expected to grow at the highest rate during the forecast period
On the basis of application, the healthcare analytics market is segmented into financial analytics, clinical analytics, operational & administrative analytics, and population health analytics. In 2021, the financial analytics segment hold the largest share of the healthcare analytics market, while the clinical analytics segment is projected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing pressure to curb healthcare costs, and federal mandates such as the implementation of ICD-10 code sets.
Services segment to hold the largest share of the healthcare analytics market
On the basis of component, the healthcare analytics market is segmented into services, hardware, and software. In 2021, the services segment accounted for the largest market share of healthcare analytics market. Factors such as end users of healthcare analytics depend on service providers for consulting, data storage, implementing services, and regular solution upgrades.
On-premise segment is expected to account for the largest share of the healthcare analytics market
On the basis of deployment model, the market is segmented into on-premise and on-demand. In 2022, on-premise segment is estimated to account for the largest share of the healthcare analytics market. The large share of this segment is primarily attributed because on-premise deployment allows end users to make use of solutions from multiple vendors, which allows customizations as per end-user requirements.
Payers segments hold the largest share of the healthcare analytics in 2021, by end user
On the basis of end users, the healthcare analytics market is segmented into providers (hospitals, physician practices, IDN, post-acute care organisations and, ambulatory settings), payers (private insurance companies, government agencies, and employers & private exchangers), and ASCOs, HIEs, & TPAs. In 2021, the payers segment holds the largest share of the healthcare analytics market. Factors such as the increasing need to curb fraudulent claims and minimize the operational price is the key factor driving the growth of this segment.
North America to be the largest and the fastest-growing regional market
North America, which includes the US and Canada, holds the largest market share for healthcare analytics market in 2021. Factors such as most of the leading players in the healthcare analytics market have their headquarters in North America, technological advancements, and high product and service availability in this region.
Breakdown of supply-side primary interviews: • By Company Type: Tier 1 – 37%, Tier 2 – 22%, and Tier 3 – 41% • By Designation: Director-level – 25%, C-level – 20%, and Others – 55% • By Region: North America – 40%, Europe – 27%, APAC –20%, Rest of the World –13%
Prominent players in this market include IBM (US), SAS Institute Inc. (US), Optum, Inc. (US), Cerner Corporation (US), Allscripts Healthcare, LLC (US), Cotiviti, Inc. (US), CitiusTech Inc (US), Health Catalyst (US), CVS Health (US), Inovalon (US), McKesson Corporation (US), MedeAnalytics, Inc. (US), Oracle (US), ExlService Holdings, Inc. (US), Gainwell (US), Wipro (US), Flatiron (US), Apixio (US), Enlitic, Inc. (US), Komodo Health, Inc. (US), HealthEC, LLC, Sema4 OpCo, Inc. (US), Evidation Health, Inc. (US), Insilico Medicine (US), Exscientia (UK), Aetion, Inc.(US), and Premier (US).
Research Coverage
This report studies the healthcare analytics market based on type, application, component, deployment model, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to two main geographies – source and destination.
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
目次
1 INTRODUCTION 39
1.1 STUDY OBJECTIVES 39
1.2 MARKET DEFINITION 39
1.2.1 INCLUSIONS AND EXCLUSIONS 40
1.2.2 MARKETS COVERED 41
FIGURE 1 HEALTHCARE ANALYTICS MARKET SEGMENTATION 41
1.2.3 YEARS CONSIDERED 42
1.3 CURRENCY CONSIDERED 42
1.4 STAKEHOLDERS 42
1.5 SUMMARY OF CHANGES 43
2 RESEARCH METHODOLOGY 44
2.1 RESEARCH APPROACH 44
2.2 RESEARCH METHODOLOGY DESIGN 44
2.2.1 SECONDARY RESEARCH 45
2.2.1.1 Key data from secondary sources 46
2.2.2 PRIMARY DATA 46
FIGURE 2 PRIMARY SOURCES 47
2.2.2.1 Key data from primary sources 47
2.2.2.2 Insights from primary experts 48
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 48
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 49
2.3 MARKET SIZE ESTIMATION 49
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 50
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION 50
FIGURE 7 REVENUE ANALYSIS OF TOP THREE PUBLIC COMPANIES: HEALTHCARE ANALYTICS MARKET (2021) 51
FIGURE 8 BOTTOM-UP APPROACH: END-USER ADOPTION/CONSUMPTION OF HEALTHCARE ANALYTICS (US) 52
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027) 54
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 55
FIGURE 11 TOP-DOWN APPROACH 55
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 56
FIGURE 12 DATA TRIANGULATION METHODOLOGY 56
2.5 MARKET SHARE ESTIMATION 57
2.6 STUDY ASSUMPTIONS 57
2.7 RESEARCH LIMITATIONS 57
2.7.1 METHODOLOGY-RELATED LIMITATIONS 57
2.7.2 SCOPE-RELATED LIMITATIONS 58
2.8 RISK ASSESSMENT 58
TABLE 1 RISK ASSESSMENT: HEALTHCARE ANALYTICS MARKET 58
3 EXECUTIVE SUMMARY 59
FIGURE 13 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 59
FIGURE 14 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 60
FIGURE 15 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION) 61
FIGURE 16 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2022 VS. 2027 (USD MILLION) 61
FIGURE 17 HEALTHCARE ANALYTICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 62
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF HEALTHCARE ANALYTICS MARKET 63
4 PREMIUM INSIGHTS 64
4.1 HEALTHCARE ANALYTICS MARKET OVERVIEW 64
FIGURE 19 GOVERNMENT INITIATIVES TO INCREASE EHR ADOPTION AND CURB HEALTHCARE COSTS 64
4.2 FINANCIAL ANALYTICS MARKET SHARE, BY TYPE AND REGION (2021) 65
FIGURE 20 NORTH AMERICA HELD LARGEST SHARE OF FINANCIAL ANALYTICS MARKET IN 2021 65
4.3 HEALTHCARE ANALYTICS MARKET: GROWTH RATES 66
FIGURE 21 US TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 66
4.4 REGIONAL MIX: HEALTHCARE ANALYTICS MARKET 66
FIGURE 22 NORTH AMERICA DOMINATED MARKET IN 2021 66
5 MARKET OVERVIEW 67
5.1 INTRODUCTION 67
5.2 MARKET DYNAMICS 67
FIGURE 23 HEALTHCARE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 67
5.2.1 DRIVERS 68
5.2.1.1 Government initiatives to increase EHR adoption 68
FIGURE 24 EHR ADOPTION RATE AMONG HOSPITALS AND PHYSICIANS (2015–2021) 68
5.2.1.2 Growing venture capital investments in healthcare analytics start-ups 69
5.2.1.3 Growing pressure to curb healthcare spending and improve patient outcomes 70
FIGURE 25 HEALTHCARE SPENDING AS PERCENTAGE OF GDP, BY COUNTRY, 2019 70
5.2.1.4 Heterogeneity and complexity of big data in healthcare 71
5.2.1.5 Growing focus on real-world evidence 71
5.2.2 RESTRAINTS 72
5.2.2.1 High cost of analytics solutions in healthcare organizations 72
5.2.2.2 Rising data breach concerns 72
5.2.3 OPPORTUNITIES 73
5.2.3.1 Increasing focus on value-based medicines 73
5.2.3.2 Use of analytics in precision and personalized medicines 73
5.2.3.3 Cloud-based analytics 74
5.2.3.4 Increasing number of patient registries 74
5.2.3.5 Emergence of social media and its impact on healthcare industry 75
5.2.3.6 Augmented analytics to supplement human intelligence 75
5.2.3.7 Growing adoption of internet of healthcare things (IoHT) 75
5.2.4 CHALLENGES 76
5.2.4.1 Concerns regarding inaccurate and inconsistent data 76
5.2.4.2 Reluctance to adopt healthcare analytics solutions in developing countries 76
5.2.4.3 Data integration for coordinated care 76
5.2.4.4 Operational gaps between payers and providers 76
5.2.4.5 Dearth of skilled personnel 77
5.3 ECOSYSTEM ANALYSIS 77
FIGURE 26 ECOSYSTEM ANALYSIS: HEALTHCARE ANALYTICS MARKET 79
5.4 VALUE CHAIN ANALYSIS 80
FIGURE 27 VALUE CHAIN ANALYSIS: HEALTHCARE ANALYTICS MARKET 80
5.5 CASE STUDY ANALYSIS 81
5.5.1 CASE STUDY 1 81
5.5.2 CASE STUDY 2 81
5.5.3 CASE STUDY 3 82
5.5.4 CASE STUDY 4 82
5.6 PORTER’S FIVE FORCES ANALYSIS 82
TABLE 2 PORTER’S FIVE FORCES ANALYSIS: HEALTHCARE ANALYTICS MARKET 82
5.6.1 THREAT FROM NEW ENTRANTS 83
5.6.2 THREAT FROM SUBSTITUTES 83
5.6.3 BARGAINING POWER OF SUPPLIERS 84
5.6.4 BARGAINING POWER OF BUYERS 84
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 84
5.7 REGULATORY ANALYSIS 84
5.7.1 NORTH AMERICA 84
5.7.2 EUROPE 85
5.7.3 ASIA PACIFIC 86
5.7.4 MIDDLE EAST & AFRICA 87
5.7.5 LATIN AMERICA 87
5.8 TECHNOLOGY ANALYSIS 87
5.8.1 MACHINE LEARNING 87
5.8.2 ARTIFICIAL INTELLIGENCE 87
5.8.3 INTERNET OF THINGS 87
5.8.4 BLOCKCHAIN 88
5.8.5 BIG DATA 88
5.9 INDUSTRY TRENDS 89
5.9.1 INCREASING PARTNERSHIPS AND COLLABORATIONS FOR INNOVATION 89
5.9.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS 89
5.9.3 CLOUD-BASED IT SOLUTIONS 90
5.10 PRICING ANALYSIS 90
TABLE 3 AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY APPLICATION 91
5.11 AVERAGE SELLING PRICE TREND ANALYSIS 91
5.12 PATENT ANALYSIS 91
FIGURE 28 PATENT ANALYSIS: HEALTHCARE ANALYTICS MARKET (JANUARY 2017–SEPTEMBER 2022) 92
5.12.1 PATENTS: HEALTHCARE ANALYTICS MARKET 92
5.13 KEY CONFERENCES AND EVENTS IN 2022–2023 93
TABLE 4 HEALTHCARE ANALYTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 93
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 94
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 94
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 94
TABLE 5 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%) 95
5.14.2 BUYING CRITERIA 95
FIGURE 30 KEY BUYING CRITERIA FOR END USERS 95
TABLE 6 KEY BUYING CRITERIA FOR END USERS 95
6 HEALTHCARE ANALYTICS MARKET, BY TYPE 96
6.1 INTRODUCTION 97
TABLE 7 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 97
6.2 DESCRIPTIVE ANALYTICS 97
6.2.1 DESCRIPTIVE ANALYTICS TO CONVERT PAST DATA INTO USEFUL INFORMATION 97
TABLE 8 HEALTHCARE ANALYTICS MARKET FOR DESCRIPTIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION) 98
6.3 PREDICTIVE ANALYTICS 98
6.3.1 GROWING USE OF PREDICTIVE ANALYTICS TO IDENTIFY HIGH-RISK PATIENTS TO DRIVE GROWTH 98
TABLE 9 HEALTHCARE ANALYTICS MARKET FOR PREDICTIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION) 100
6.4 PRESCRIPTIVE ANALYTICS 100
6.4.1 PRESCRIPTIVE ANALYTICS TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 100
TABLE 10 HEALTHCARE ANALYTICS MARKET FOR PRESCRIPTIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION) 101
6.5 COGNITIVE ANALYTICS 101
6.5.1 INTRODUCTION OF AI-DRIVEN ANALYTICS SOLUTIONS TO BOOST MARKET 101
TABLE 11 HEALTHCARE ANALYTICS MARKET FOR COGNITIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION) 102
7 HEALTHCARE ANALYTICS MARKET, BY COMPONENT 103
7.1 INTRODUCTION 104
TABLE 12 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 104
7.2 SERVICES 104
TABLE 13 HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 14 HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY REGION, 2020–2027 (USD MILLION) 105
7.2.1 SUPPORT SERVICES 105
7.2.1.1 Support services to include implementation, ongoing IT support, system integration, training, and maintenance services 105
TABLE 15 HEALTHCARE ANALYTICS SUPPORT SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 106
7.2.2 BUSINESS ANALYTICS SERVICES 106
7.2.2.1 Business analytics services to help healthcare organizations optimize use of analytics and drive performance improvement 106
TABLE 16 HEALTHCARE BUSINESS ANALYTICS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 107
7.3 SOFTWARE 107
7.3.1 HEALTHCARE ANALYTICS SOFTWARE TO WORK AS INTERFACE BETWEEN DATABASE AND END USERS 107
TABLE 17 HEALTHCARE ANALYTICS MARKET FOR SOFTWARE, BY REGION, 2020–2027 (USD MILLION) 108
7.4 HARDWARE 108
7.4.1 INCREASING ADOPTION OF CLOUD SERVERS TO HINDER GROWTH 108
TABLE 18 HEALTHCARE ANALYTICS MARKET FOR HARDWARE, BY REGION, 2020–2027 (USD MILLION) 109
8 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL 110
8.1 INTRODUCTION 111
TABLE 19 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 111
8.2 ON-PREMISE DEPLOYMENT 111
8.2.1 MULTIVENDOR ARCHITECTURE TO LOWER RISK OF DATA BREACHES AND EXTERNAL ATTACKS 111
TABLE 20 ON-PREMISE SOLUTIONS AVAILABLE 112
TABLE 21 HEALTHCARE ANALYTICS MARKET FOR ON-PREMISE DEPLOYMENT MODEL, BY REGION, 2020–2027 (USD MILLION) 112
8.3 ON-DEMAND DEPLOYMENT 112
8.3.1 INCREASING VOLUME OF DATA GENERATED TO DRIVE ADOPTION 112
TABLE 22 ON-DEMAND SOLUTIONS AVAILABLE 113
TABLE 23 HEALTHCARE ANALYTICS MARKET FOR ON-DEMAND DEPLOYMENT MODEL, BY REGION, 2020–2027 (USD MILLION) 113
9 HEALTHCARE ANALYTICS MARKET, BY APPLICATION 114
9.1 INTRODUCTION 115
TABLE 24 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 115
9.2 FINANCIAL ANALYTICS 115
TABLE 25 COMMERCIALLY AVAILABLE FINANCIAL ANALYTICS SOLUTIONS 116
TABLE 26 HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 116
TABLE 27 HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY REGION, 2020–2027 (USD MILLION) 117
9.2.1 CLAIMS PROCESSING 117
9.2.1.1 Improvement in claims response time and avoidance of fraudulent claims to support market 117
TABLE 28 COMMERCIALLY AVAILABLE CLAIMS PROCESSING SOLUTIONS 117
TABLE 29 HEALTHCARE ANALYTICS MARKET FOR CLAIMS PROCESSING, BY REGION, 2020–2027 (USD MILLION) 118
9.2.2 REVENUE CYCLE MANAGEMENT 118
9.2.2.1 Healthcare organizations to adopt predictive analytics solutions for proactive decision-making 118
TABLE 30 COMMERCIALLY AVAILABLE REVENUE CYCLE MANAGEMENT SOLUTIONS 118
TABLE 31 HEALTHCARE ANALYTICS MARKET FOR REVENUE CYCLE MANAGEMENT, BY REGION, 2020–2027 (USD MILLION) 119
9.2.3 PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE (FWA) 119
9.2.3.1 Implementation of ICD-10 code sets and adoption of fee-for-value systems to boost market 119
TABLE 32 COMMERCIALLY AVAILABLE PAYMENT INTEGRITY & FWA SOLUTIONS 120
TABLE 33 HEALTHCARE ANALYTICS MARKET FOR PAYMENT INTEGRITY & FWA, BY REGION, 2020–2027 (USD MILLION) 120
9.2.4 RISK ADJUSTMENT & ASSESSMENT 121
9.2.4.1 Optimization of cash flows and improved financial performance to aid market 121
TABLE 34 COMMERCIALLY AVAILABLE RISK ADJUSTMENT & ASSESSMENT SOLUTIONS 121
TABLE 35 HEALTHCARE ANALYTICS MARKET FOR RISK ADJUSTMENT & ASSESSMENT, BY REGION, 2020–2027 (USD MILLION) 121
9.3 CLINICAL ANALYTICS 122
TABLE 36 COMMERCIALLY AVAILABLE CLINICAL ANALYTICS SOLUTIONS 122
TABLE 37 HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 38 HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY REGION, 2020–2027 (USD MILLION) 123
9.3.1 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING 124
9.3.1.1 Benchmarking to identify and manage issues that negatively impact healthcare systems 124
TABLE 39 COMMERCIALLY AVAILABLE QUALITY IMPROVEMENT & CLINICAL BENCHMARKING SOLUTIONS 124
TABLE 40 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING MARKET, BY REGION, 2020–2027 (USD MILLION) 125
9.3.2 CLINICAL DECISION SUPPORT 125
9.3.2.1 Reduction of medical errors and performance of appropriate tests to augment market 125
TABLE 41 COMMERCIALLY AVAILABLE SOLUTIONS FOR CLINICAL DECISION SUPPORT 126
TABLE 42 CLINICAL DECISION SUPPORT MARKET, BY REGION, 2020–2027 (USD MILLION) 126
9.3.3 REPORTING & COMPLIANCE 126
9.3.3.1 Stringent regulatory requirements to accelerate market 126
TABLE 43 COMMERCIALLY AVAILABLE SOLUTIONS FOR REPORTING & COMPLIANCE 127
TABLE 44 REPORTING & COMPLIANCE MARKET, BY REGION, 2020–2027 (USD MILLION) 127
9.3.4 COMPARATIVE ANALYTICS/EFFECTIVENESS 127
9.3.4.1 Growing adoption of EHRs to provide growth 127
TABLE 45 COMMERCIALLY AVAILABLE SOLUTIONS FOR COMPARATIVE ANALYTICS/EFFECTIVENESS 127
TABLE 46 COMPARATIVE ANALYTICS/EFFECTIVENESS MARKET, BY REGION, 2020–2027 (USD MILLION) 128
9.3.5 PRECISION HEALTH 128
9.3.5.1 Strong government support for personalized medicine to drive market 128
TABLE 47 COMMERCIALLY AVAILABLE PRECISION HEALTH SOLUTIONS 128
TABLE 48 PRECISION HEALTH MARKET, BY REGION, 2020–2027 (USD MILLION) 129
9.3.6 MEDICAL IMAGING ANALYTICS 129
9.3.6.1 Imaging analytics aided by artificial intelligence and machine learning to fuel market 129
TABLE 49 COMMERCIALLY AVAILABLE SOLUTIONS FOR MEDICAL IMAGING ANALYTICS 130
TABLE 50 MEDICAL IMAGING ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION) 130
9.4 OPERATIONAL & ADMINISTRATIVE ANALYTICS 130
TABLE 51 COMMERCIALLY AVAILABLE SOLUTIONS FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS 130
TABLE 52 HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 53 HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION) 131
9.4.1 SUPPLY CHAIN ANALYTICS 132
9.4.1.1 Informed decisions about costs, medication, and equipment to propel market 132
TABLE 54 COMMERCIALLY AVAILABLE SUPPLY CHAIN ANALYTICS SOLUTIONS 132
TABLE 55 SUPPLY CHAIN ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION) 132
9.4.2 WORKFORCE ANALYTICS 133
9.4.2.1 Need for real-time resource demand and supply data to drive adoption of workforce analytics 133
TABLE 56 COMMERCIALLY AVAILABLE WORKFORCE ANALYTICS SOLUTIONS 133
TABLE 57 WORKFORCE ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION) 133
9.4.3 STRATEGIC ANALYTICS 134
9.4.3.1 Strategic analytics to use advanced analytics tools and leverage operational data 134
TABLE 58 STRATEGIC ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION) 134
9.5 POPULATION HEALTH ANALYTICS 134
9.5.1 IMPROVING POPULATION HEALTH OUTCOMES AND LOWERING COSTS TO DRIVE GROWTH 134
TABLE 59 COMMERCIALLY AVAILABLE POPULATION HEALTH ANALYTICS SOLUTIONS 135
TABLE 60 HEALTHCARE ANALYTICS MARKET FOR POPULATION HEALTH ANALYTICS, BY REGION, 2020–2027 (USD MILLION) 135
10 HEALTHCARE ANALYTICS MARKET, BY END USER 136
10.1 INTRODUCTION 137
TABLE 61 HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 137
10.2 PAYERS 137
TABLE 62 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 63 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY REGION, 2020–2027 (USD MILLION) 138
10.2.1 PRIVATE INSURANCE COMPANIES 139
10.2.1.1 Private insurance companies to account for largest market share 139
TABLE 64 PRIVATE INSURANCE COMPANIES MARKET, BY REGION, 2020–2027 (USD MILLION) 139
10.2.2 GOVERNMENT AGENCIES 139
10.2.2.1 Increasing use of analytics solutions to boost market 139
TABLE 65 GOVERNMENT AGENCIES MARKET, BY REGION, 2020–2027 (USD MILLION) 140
10.2.3 EMPLOYERS & PRIVATE EXCHANGES 140
10.2.3.1 Employers & private exchanges to use data analytics for rapid data integration, health plan analysis, and risk modeling 140
TABLE 66 EMPLOYERS & PRIVATE EXCHANGES MARKET, BY REGION, 2020–2027 (USD MILLION) 141
10.3 PROVIDERS 141
TABLE 67 HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 142
10.3.1 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS 142
10.3.1.1 Adoption of healthcare analytics solutions to drive growth 142
TABLE 68 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS MARKET, BY REGION, 2020–2027 (USD MILLION) 144
10.3.2 POST-ACUTE CARE ORGANIZATIONS 144
10.3.2.1 Post-acute care organizations to review and study patient data using healthcare analytics 144
TABLE 69 POST-ACUTE CARE ORGANIZATIONS MARKET, BY REGION,2020–2027 (USD MILLION) 145
10.3.3 AMBULATORY SETTINGS 145
10.3.3.1 Management of population health and need to control healthcare costs to support market 145
TABLE 70 AMBULATORY SETTINGS MARKET, BY REGION, 2020–2027 (USD MILLION) 146
10.4 ACOS, HIES, MCOS, AND TPAS 146
TABLE 71 HEALTHCARE ANALYTICS MARKET FOR ACOS, HIES, MCOS, AND TPAS, BY REGION, 2020–2027 (USD MILLION) 148
11 HEALTHCARE ANALYTICS MARKET, BY REGION 149
11.1 INTRODUCTION 150
TABLE 72 HEALTHCARE ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION) 150
11.2 NORTH AMERICA 150
FIGURE 31 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2021) 151
TABLE 73 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 152
TABLE 74 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 75 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 153
TABLE 76 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION) 153
TABLE 77 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 78 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 79 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 155
TABLE 80 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 81 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 155
TABLE 82 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 156
TABLE 83 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 84 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 157
11.2.1 US 157
11.2.1.1 High adoption of EHRs to drive market 157
TABLE 85 US: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 86 US: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 87 US: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 88 US: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 89 US: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 90 US: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 160
TABLE 91 US: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 92 US: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 161
TABLE 93 US: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 161
TABLE 94 US: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 95 US: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 162
11.2.2 CANADA 162
11.2.2.1 Need for managing patient volumes, clinical data, and healthcare costs to fuel market 162
TABLE 96 CANADA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 97 CANADA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 163
TABLE 98 CANADA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 164
TABLE 99 CANADA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 164
TABLE 100 CANADA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 101 CANADA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 165
TABLE 102 CANADA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 103 CANADA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 166
TABLE 104 CANADA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 166
TABLE 105 CANADA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 106 CANADA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 167
11.3 EUROPE 167
FIGURE 32 EUROPE: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2021) 168
TABLE 107 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 169
TABLE 108 EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027(USD MILLION) 169
TABLE 109 EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 170
TABLE 110 EUROPE: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 170
TABLE 111 EUROPE: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 112 EUROPE: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 113 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 172
TABLE 114 EUROPE: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 115 EUROPE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 172
TABLE 116 EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 173
TABLE 117 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 118 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 173
11.3.1 GERMANY 174
11.3.1.1 Government initiatives to increase use of analytics in healthcare 174
TABLE 119 GERMANY: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 120 GERMANY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 121 GERMANY: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION) 175
TABLE 122 GERMANY: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 123 GERMANY: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 124 GERMANY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 177
TABLE 125 GERMANY: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION) 177
TABLE 126 GERMANY: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 177
TABLE 127 GERMANY: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 178
TABLE 128 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 129 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 178
11.3.2 UK 179
11.3.2.1 Availability of venture capital investments to drive market 179
TABLE 130 UK: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 131 UK: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 180
TABLE 132 UK: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 133 UK: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 134 UK: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 135 UK: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 182
TABLE 136 UK: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 137 UK: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 182
TABLE 138 UK: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 183
TABLE 139 UK: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 140 UK: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 183
11.3.3 FRANCE 184
11.3.3.1 Strong financial support for digital health to augment market 184
TABLE 141 FRANCE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 184
TABLE 142 FRANCE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 185
TABLE 143 FRANCE: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 144 FRANCE: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 186
TABLE 145 FRANCE: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 186
TABLE 146 FRANCE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 187
TABLE 147 FRANCE: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION) 187
TABLE 148 FRANCE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 187
TABLE 149 FRANCE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 188
TABLE 150 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 151 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 188
11.3.4 REST OF EUROPE 189
TABLE 152 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 153 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 190
TABLE 154 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION) 190
TABLE 155 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 156 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 157 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 192
TABLE 158 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 159 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 192
TABLE 160 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 193
TABLE 161 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 162 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 193
11.4 ASIA 194
FIGURE 33 ASIA: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2021) 195
TABLE 163 ASIA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 196
TABLE 164 ASIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 165 ASIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 196
TABLE 166 ASIA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 197
TABLE 167 ASIA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION) 197
TABLE 168 ASIA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 198
TABLE 169 ASIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 198
TABLE 170 ASIA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION) 198
TABLE 171 ASIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 199
TABLE 172 ASIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 199
TABLE 173 ASIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION) 199
TABLE 174 ASIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 200
11.4.1 JAPAN 200
11.4.1.1 Rise in geriatric population to demand effective patient management solutions 200
TABLE 175 JAPAN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 176 JAPAN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 201
TABLE 177 JAPAN: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 178 JAPAN: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 202
TABLE 179 JAPAN: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 202
TABLE 180 JAPAN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 203
TABLE 181 JAPAN: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION) 203
TABLE 182 JAPAN: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 203
TABLE 183 JAPAN: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 204
TABLE 184 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 185 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 204
11.4.2 CHINA 205
11.4.2.1 Favorable reforms and growing number of EHRs to aid market 205
TABLE 186 CHINA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 205
TABLE 187 CHINA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 206
TABLE 188 CHINA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 206
TABLE 189 CHINA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 207
TABLE 190 CHINA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 207
TABLE 191 CHINA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 208
TABLE 192 CHINA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION) 208
TABLE 193 CHINA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 208
TABLE 194 CHINA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 209
TABLE 195 CHINA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION) 209
TABLE 196 CHINA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 209
11.4.3 INDIA 210
11.4.3.1 Low healthcare expenditure by government and slow adoption of healthcare analytics solutions to restrain market 210
TABLE 197 INDIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 211
TABLE 198 INDIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 211
TABLE 199 INDIA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 211
TABLE 200 INDIA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 212
TABLE 201 INDIA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 212
TABLE 202 INDIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 213
TABLE 203 INDIA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION) 213
TABLE 204 INDIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 213
TABLE 205 INDIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 214
TABLE 206 INDIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION) 214
TABLE 207 INDIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 214
11.4.4 REST OF ASIA 215
TABLE 208 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 215
TABLE 209 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 216
TABLE 210 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 216
TABLE 211 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 217
TABLE 212 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 217
TABLE 213 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 218
TABLE 214 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION) 218
TABLE 215 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 218
TABLE 216 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 219
TABLE 217 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION) 219
TABLE 218 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 219
11.5 PACIFIC COUNTRIES 220
11.5.1 NEED TO REDUCE HEALTHCARE COSTS IN AUSTRALIA AND NEW ZEALAND TO DRIVE MARKET 220
TABLE 219 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 220
TABLE 220 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 221
TABLE 221 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 221
TABLE 222 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION) 222
TABLE 223 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 222
TABLE 224 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 223
TABLE 225 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION) 223
TABLE 226 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 223
TABLE 227 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 224
TABLE 228 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION) 224
TABLE 229 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 224
11.6 LATIN AMERICA 225
11.6.1 GROWING E-HEALTH INITIATIVES TO PROPEL MARKET 225
TABLE 230 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 225
TABLE 231 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 226
TABLE 232 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 226
TABLE 233 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 227
TABLE 234 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 227
TABLE 235 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 228
TABLE 236 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION) 228
TABLE 237 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 228
TABLE 238 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 229
TABLE 239 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION) 229
TABLE 240 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 229
11.7 MIDDLE EAST & AFRICA 230
11.7.1 HIGH HEALTHCARE EXPENDITURE AND INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET 230
TABLE 241 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 231
TABLE 242 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 231
TABLE 243 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 232
TABLE 244 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION) 232
TABLE 245 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION) 233
TABLE 246 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 233
TABLE 247 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION) 233
TABLE 248 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 234
TABLE 249 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 234
TABLE 250 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION) 234
TABLE 251 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 235
12 COMPETITIVE LANDSCAPE 236
12.1 INTRODUCTION 236
12.2 STRATEGIES ADOPTED BY KEY PLAYERS 236
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS 237
12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 239
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE ANALYTICS MARKET 239
12.4 MARKET RANKING ANALYSIS, 2021 239
FIGURE 35 HEALTHCARE ANALYTICS MARKET RANKING ANALYSIS, 2021 240
12.5 COMPANY LEADERSHIP MAPPING 241
12.5.1 STARS 241
12.5.2 PERVASIVE PLAYERS 241
12.5.3 EMERGING LEADERS 241
12.5.4 PARTICIPANTS 241
FIGURE 36 HEALTHCARE ANALYTICS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021 242
12.6 COMPETITIVE LEADERSHIP MAPPING: START-UPS/SMES (2021) 242
12.6.1 PROGRESSIVE COMPANIES 242
12.6.2 STARTING BLOCKS 242
12.6.3 RESPONSIVE COMPANIES 243
12.6.4 DYNAMIC COMPANIES 243
FIGURE 37 HEALTHCARE ANALYTICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021 243
12.7 COMPETITIVE BENCHMARKING 244
FIGURE 38 OVERALL FOOTPRINT OF COMPANIES (17 COMPANIES) 244
TABLE 252 APPLICATION FOOTPRINT OF COMPANIES 245
TABLE 253 END-USER FOOTPRINT OF COMPANIES 246
TABLE 254 REGIONAL FOOTPRINT OF COMPANIES 247
12.8 COMPETITIVE SCENARIO 247
12.8.1 PRODUCT LAUNCHES & APPROVALS 248
TABLE 255 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2019–OCTOBER 2022 248
12.8.2 DEALS 250
TABLE 256 DEALS, JANUARY 2019–OCTOBER 2022 250
12.8.3 OTHER DEVELOPMENTS 254
TABLE 257 OTHER DEVELOPMENTS, JANUARY 2019–OCTOBER 2022 254
13 COMPANY PROFILES 256
(Business overview, Products/Services/Solutions offered, Recent Developments, MNM view)*
13.1 KEY PLAYERS 256
13.1.1 IBM 256
TABLE 258 IBM: COMPANY OVERVIEW 256
FIGURE 39 IBM: COMPANY SNAPSHOT (2021) 257
13.1.2 SAS INSTITUTE INC. 261
TABLE 259 SAS INSTITUTE INC.: COMPANY OVERVIEW 261
FIGURE 40 SAS INSTITUTE INC.: COMPANY SNAPSHOT (2021) 262
13.1.3 OPTUM, INC. 266
TABLE 260 OPTUM, INC.: COMPANY OVERVIEW 266
FIGURE 41 OPTUM, INC.: COMPANY SNAPSHOT (2021) 266
13.1.4 CERNER CORPORATION 270
TABLE 261 CERNER CORPORATION: COMPANY OVERVIEW 270
FIGURE 42 CERNER CORPORATION: COMPANY SNAPSHOT (2021) 271
13.1.5 ALLSCRIPTS HEALTHCARE, LLC 275
TABLE 262 ALLSCRIPTS HEALTHCARE, LLC: COMPANY OVERVIEW 275
FIGURE 43 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021) 276
13.1.6 COTIVITI, INC. 281
TABLE 263 COTIVITI, INC.: COMPANY OVERVIEW 281
13.1.7 CITIUSTECH INC. 284
TABLE 264 CITIUSTECH INC.: COMPANY OVERVIEW 284
13.1.8 HEALTH CATALYST 287
TABLE 265 HEALTH CATALYST: COMPANY OVERVIEW 287
FIGURE 44 HEALTH CATALYST: COMPANY SNAPSHOT (2021) 287
13.1.9 CVS HEALTH 291
TABLE 266 CVS HEALTH: COMPANY OVERVIEW 291
FIGURE 45 CVS HEALTH: COMPANY SNAPSHOT (2021) 291
13.1.10 INOVALON 293
TABLE 267 INOVALON: COMPANY OVERVIEW 293
FIGURE 46 INOVALON: COMPANY SNAPSHOT (2021) 293
13.1.11 MCKESSON CORPORATION 297
TABLE 268 MCKESSON CORPORATION: COMPANY OVERVIEW 297
FIGURE 47 MCKESSON CORPORATION.: COMPANY SNAPSHOT (2021) 297
13.1.12 MEDEANALYTICS, INC. 299
TABLE 269 MEDEANALYTICS, INC.: COMPANY OVERVIEW 299
13.1.13 ORACLE 302
TABLE 270 ORACLE: COMPANY OVERVIEW 302
FIGURE 48 ORACLE: COMPANY SNAPSHOT (2022) 303
13.1.14 EXLSERVICE HOLDINGS, INC. 306
TABLE 271 EXLSERVICE HOLDINGS, INC.: COMPANY OVERVIEW 306
FIGURE 49 EXLSERVICE HOLDINGS, INC.: COMPANY SNAPSHOT (2021) 307
13.1.15 GAINWELL. 309
TABLE 272 GAINWELL: COMPANY OVERVIEW 309
13.1.16 WIPRO 310
TABLE 273 WIPRO: COMPANY OVERVIEW 310
FIGURE 50 WIPRO: COMPANY SNAPSHOT (2022) 311
13.2 OTHER PLAYERS 313
13.2.1 FLATIRON 313
TABLE 274 FLATIRON: COMPANY OVERVIEW 313
13.2.2 APIXIO 315
TABLE 275 APIXIO: COMPANY OVERVIEW 315
13.2.3 ENLITIC, INC. 317
TABLE 276 ENLITIC, INC.: COMPANY OVERVIEW 317
13.2.4 KOMODO HEALTH, INC. 319
TABLE 277 KOMODO HEALTH, INC.: COMPANY OVERVIEW 319
13.2.5 HEALTHEC, LLC 321
TABLE 278 HEALTHEC, LLC: COMPANY OVERVIEW 321
13.2.6 SEMA4 OPCO, INC. 322
13.2.7 EVIDATION HEALTH, INC. 322
13.2.8 INSILICO MEDICINE 323
13.2.9 EXSCIENTIA 324
13.2.10 AETION, INC. 325
13.2.11 PREMIER 325
*Details on Business overview, Products/Services/Solutions offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
14 APPENDIX 326
14.1 DISCUSSION GUIDE 326
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 331
14.3 CUSTOMIZATION OPTIONS 333
14.4 RELATED REPORTS 333
14.5 AUTHOR DETAILS 334